PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.22%
Negative revenue growth while CX stands at 17.55%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-71.13%
Negative gross profit growth while CX is at 31.95%. Joel Greenblatt would examine cost competitiveness or demand decline.
-92.68%
Negative EBIT growth while CX is at 94.77%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-92.68%
Negative operating income growth while CX is at 94.77%. Joel Greenblatt would press for urgent turnaround measures.
-0.27%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.96%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.17%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
336.77%
10Y revenue/share CAGR above 1.5x CX's 19.93%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
218.02%
5Y revenue/share CAGR 1.25-1.5x CX's 190.09%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
97.74%
3Y revenue/share CAGR above 1.5x CX's 35.06%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
241.78%
Positive 10Y CAGR while CX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
490.92%
5Y net income/share CAGR above 1.5x CX's 22.74%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
99.03%
Positive short-term CAGR while CX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
143.10%
5Y equity/share CAGR is in line with CX's 132.92%. Walter Schloss would see parallel mid-term profitability and retention policies.
79.17%
3Y equity/share CAGR similar to CX's 73.42%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.